Status:
COMPLETED
Prognostic Value of Tumor Deposits for Patients With Papillary Thyroid Carcinoma
Lead Sponsor:
Nanfang Hospital, Southern Medical University
Conditions:
Exploring the Prognostic Value of Tumor Deposits PTC Patients
Eligibility:
All Genders
Brief Summary
Tumor deposits (TD), nodules in the peritumoral adipose tissue with no architectural residue of lymph node, which is a definition often being confusing to the extranodal extension (ENE), have been des...
Eligibility Criteria
Inclusion
- (1) patients with histopathologically confirmed PTC and sections stored in the pathology department; (2) patients underwent lobectomy or total thyroidectomy and central lymph node dissection with or without lateral neck dissection; (3) patients cooperated to provide follow-up information after surgery.
Exclusion
- (1) patients with previous history of neck irradiation or other systematic cancers; (2) patients died of unrelated diseases.
Key Trial Info
Start Date :
November 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2023
Estimated Enrollment :
541 Patients enrolled
Trial Details
Trial ID
NCT06051838
Start Date
November 1 2022
End Date
March 30 2023
Last Update
September 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China, 510515